These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 8750621
1. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Martyré MC. Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621 [Abstract] [Full Text] [Related]
2. Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis. Le Bousse-Kerdilès MC, Martyré MC, French INSERM research network on Idiopathic Myelofibrosis. Pathol Biol (Paris); 2001 Mar; 49(2):153-7. PubMed ID: 11317961 [Abstract] [Full Text] [Related]
3. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. Bock O, Loch G, Schade U, von Wasielewski R, Schlué J, Kreipe H. J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648 [Abstract] [Full Text] [Related]
4. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Le Bousse-Kerdilès MC, Martyré MC. Ann Hematol; 1999 Oct; 78(10):437-44. PubMed ID: 10550553 [Abstract] [Full Text] [Related]
5. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia. Michiels JJ. Neth J Med; 1997 Aug; 51(2):57-64. PubMed ID: 9286142 [Abstract] [Full Text] [Related]
6. Megakaryocytes and platelets in myeloproliferative disorders. Briere J, Kiladjian JJ, Peynaud-Debayle E. Baillieres Clin Haematol; 1997 Feb; 10(1):65-88. PubMed ID: 9154316 [Abstract] [Full Text] [Related]
7. Current perspective in agnogenic myeloid metaplasia. Tefferi A, Silverstein MN. Leuk Lymphoma; 1996 Sep; 22 Suppl 1():169-71. PubMed ID: 8951788 [Abstract] [Full Text] [Related]
16. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models. Chagraoui H, Wendling F, Vainchenker W. Best Pract Res Clin Haematol; 2006 Jan 18; 19(3):399-412. PubMed ID: 16781480 [Abstract] [Full Text] [Related]
17. [Megakaryocytopoiesis in myeloproliferative disorders]. Podolak-Dawidziak M. Acta Haematol Pol; 1992 Jan 18; 23(2 Suppl 1):19-22. PubMed ID: 1488868 [No Abstract] [Full Text] [Related]
18. Abnormal myelopoietic clones in man. McCulloch EA. J Natl Cancer Inst; 1979 Oct 18; 63(4):883-92. PubMed ID: 384008 [No Abstract] [Full Text] [Related]
19. Stem cell origin of human myeloid blood cell neoplasms. Fialkow PJ. Verh Dtsch Ges Pathol; 1990 Oct 18; 74():43-7. PubMed ID: 1708632 [Abstract] [Full Text] [Related]
20. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia. Wang JC, Chang TH, Goldberg A, Novetsky AD, Lichter S, Lipton J. Exp Hematol; 2006 Dec 18; 34(12):1617-23. PubMed ID: 17157157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]